Related Experiment Video
Updated: Mar 25, 2026

Point-Of-Care Ultrasound Screening for Proximal Lower Extremity Deep Venous Thrombosis
Published on: February 10, 2023
Venous thromboembolism - prevalence and risk factors in chronic venous disease patients
Dalibor Musil1, Markéta Kaletová1, Jiří Herman2
11 Department of Internal Medicine I - Cardiology, Teaching Hospital, Olomouc, Czech Republic.
Insights
The prevalence of venous thromboembolism (VTE) in chronic venous disease patients is 5%. Advanced age (≥70 years) and obesity significantly increase VTE risk in these patients.
Area of Science:
- Vascular Medicine
- Epidemiology
Background:
- Chronic venous disease (CVD) affects a significant portion of the population.
- Venous thromboembolism (VTE) is a serious complication that can occur in patients with CVD.
- Understanding the prevalence and risk factors for VTE in CVD patients is crucial for effective management.
Purpose of the Study:
- To investigate the prevalence of venous thromboembolism (VTE) in patients diagnosed with chronic venous disease (CVD).
- To identify intrinsic and extrinsic risk factors associated with the occurrence of VTE in this patient cohort.
Main Methods:
- A retrospective study was conducted on 641 outpatients with primary chronic venous disease (CVD).
- Data collected included patient demographics, body mass index (BMI), family history of VTE, CEAP clinical classification, smoking status, and hormone therapy use.
- The prevalence of VTE was analyzed in relation to these potential risk factors.
Main Results:
- The overall prevalence of VTE episodes was 5% among patients with CVD, with no significant gender predominance.
- Age ≥70 years (OR 3.2-4.78) and obesity (p=0.002) were strongly associated with an increased risk of VTE.
- Chronic venous insufficiency showed a higher prevalence of VTE (55.3%) compared to varicose veins (44.7%).
- Family history of VTE, smoking, and hormone therapy were not found to be significant independent risk factors for VTE.
Conclusions:
- The 5% VTE prevalence in CVD patients is comparable to the general European population.
- Age ≥70 years and obesity are significant risk factors for VTE in patients with chronic venous disease.
- Obese patients with CVD face a higher VTE risk than obese individuals in the general population, highlighting the need for targeted prevention strategies.
Abstract:
Aims This study was aimed to investigate the prevalence of venous thromboembolism in patients with chronic venous disease and the impact of some intrinsic and extrinsic risk factors. Methods A retrospective study on 641 outpatients (489 women) with primary chronic venous disease (C0-C6). The prevalence of venous thromboembolism was evaluated according to sex, age, BMI, the presence of ≥1 first-degree siblings diagnosed with venous thromboembolism, CEAP clinical class, smoking and the use of hormone therapy. Results Venous thromboembolism episodes occurred in 32 patients (5%) with no gender predominance (OR 1.49, 95% CI = 0.90-2.45; p = 0.146). There was no increased RR of venous thromboembolism in the age group 46-69 years compared with patients aged ≤45 years ( p = 0.350). In persons aged ≥70 years, the risk of venous thromboembolism was 3.2 times higher than in patients aged 46-69 years and 4.78 times higher than in patients aged ≤45 years. The risk of venous thromboembolism rose very significantly in obese compared with normostenic patients ( p = 0.002). There were significantly more venous thromboembolism episodes in patients with chronic venous insufficiency (55.3%) than patients with varicose veins (44.7%) ( p < 0.001). A family history of venous thromboembolism ( p = 0.12), smoking ( p = 0.905) and hormone therapy ( p = 0.326) were not associated with increased risk of venous thromboembolism. Smoking was a risk factor in obese patients ( p = 0.033), but the combination of obesity, smoking, estrogens in women did not increase the risk of venous thromboembolism. Conclusions The 5% prevalence of venous thromboembolism episodes in patients was comparable with the prevalence of venous thromboembolism in the general European population. Age ≥70 years and obesity were strongly associated with an occurrence of venous thromboembolism. Obese patients with chronic venous disease were at higher risk for venous thromboembolism than obese people in the general population. A family history of venous thromboembolism, smoking and estrogens alone or in combination were not revealed as significant risk factors.
Related Concept Videos
Venous Thrombosis I: Introduction
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis IV: Nursing Management
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Varicose Veins I: Introduction
Pulmonary Embolism III: Nursing Management

